A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration

Blood

Volumn 112, Issue 6, 2008, Pages 2353-2359

  Van De Ven, Rieneke ^a   Seheffer, George L ^a   Reurs, Anneke W ^a   Lindenberg, Jelle J ^a   Oerlemans, Ruud ^a   Jansen, Gerrit ^a   Gillet, Jean Pierre ^b   Glasgow, Joel N ^c   Pereboev, Alexander ^c   Curiel, David T ^c   Scheper, Rik J ^a   De Gruijl, Tanja D ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NAMUR   (Belgium)

^c University of Alabama at Birmingham   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC NUCLEOTIDE; LEUKOTRIENE B4; MULTIDRUG RESISTANCE PROTEIN 4; PROSTAGLANDIN E2; PROTEIN ABCC4; RNA; UNCLASSIFIED DRUG; ABCC4 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; T LYMPHOCYTE; CELL CULTURE; CELL MOTION; CYTOLOGY; EPIDERMIS; LYMPH NODE; PHYSIOLOGY; SKIN;

CELL MOVEMENT; CELLS, CULTURED; DENDRITIC CELLS; EPIDERMIS; HUMANS; LANGERHANS CELLS; LYMPH NODES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; SKIN;

EID: 55249123453     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-03-147850     Document Type: Article

References (42)

1. Borst P. Evers R. Kool M. Wijnholds J. Afamily of drug transporters: the multidrug resistanceassociated proteins. J Natl Cancer Inst. 2000;92: 1295-1302.
2. Raggers RJ, Vogels I, van Meer G. Multidrugresistance P-glycoprotein (MDR1) secretes platelet-activating factor. Biochem J. 2001;357: 859-865.
3. Leier I. Jedlitschky G. Buchholz U. et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem. 1994269:27807-27810.
4. Reid G, Wielinga P. Zelcer N et al. The human multidrug resistance protein MRP4functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA. 2003;100:9244-9249.
5. Schuurhuis DH. Fu N. Ossendorp F, Melief CJ. Ins and outs of dendritic cells. Int Arch Allergy Immunol. 2006;140:53-72.
6. deGruijITD, OphorstOJ, GoudsmitJ, etal. Intradermal delivery of adenoviral type-35 vectors leads to high efficiency transduction of mature, CD8+ T cell-stimulating skin-emigrated dendritic cells. J Immunol. 2006:177:2208-2215.
7. van de Ven R. de Jong MC, ReursAW, et al. Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiation. J Immunol. 2006;176:5191-5198.
8. Randolph GJ, Beaulieu S, Pope M, et al. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc Natl Acad Sci USA. 1998;95:6924-6929.
9. Robbiani DF, Finch RA, Jager D, et al. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell. 2000;103:757-768.
10. Allikmets R. Gerrard B, Hutchinson A. Dean M. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. Hum Mol Genet. 1996:5:1649-1655.
11. Kool M.deHaasM, Scheffer GL, et al. Analysis of expression of cMOAT(MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997;57: 3537-3547.
12. Borst P. de Wolf C, van deWetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflugers Arch. 2007;453:661-673.
13. LuftT, Jefford M, Luetjens P. et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood. 2002;100:1362-1372.
14. ScandellaE, Men Y, Legler DF, et al. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood. 2004;103:1595-1601.
15. Legler DF, Krause P, Scandella E, Singer E, Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J Immunol. 2006;176:966-973.
16. Rius M, Hummel-Eisenbeiss J, Keppler D. ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4). J Pharmacol ExpTher. 2008;324:86-94.
17. Hu ZB, MaW, Zaborski M, et al. Establishment and characterization of two novel cytokineresponsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia. 1996:10:1025-1040.
18. MastersonAJ, Sombroek CC, de GruijI TD, et al. MUTZ-3, a human cell line model for the cytokineinduced differentiation of dendritic cells from CD34+ precursors. Blood. 2002;100:701-703.
19. Santegoets SJ, MastersonAJ, van der Sluis PC, et al. ACD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor. J Leukoc Biol. 2006;80:1337-1344.
20. Reid G, Wielinga P, Zelcer N, et al. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol Pharmacol. 2003:63: 1094-1103.
21. Wielinga PR, Reid G, Challa EE, et al. Thiopurine metabolism and identification of the thiopurine metabolites transported by MRP4 and MRP5 overexpressed in human embryonic kidney cells. Mol Pharmacol. 2002;62:1321-1331.
22. Zijlstra JG.de Vries EG, Mulder NH. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 1987:47:1780-1784.
23. SchroeijersAB, ReursAW, Scheffer GL, et al. Upregulation of drug resistance-related vaults during dendritic cell development. J Immunol. 2002;168: 1572-1578.
24. Leggas M, Adachi M, Scheffer GL, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004:24: 7612-7621.
25. de Gruijl TD, Luykx-de Bakker SA, Tillman BW, et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol. 2002:169:5322-5331.
26. PereboevAV, Nagle JM, Shakhmatov MA, et al. Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Mol Ther. 2004:9:712-720.
27. Gillet JP. Efferth T, Steinbach D, et al. Microarraybased detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res. 2004; 64:8987-8993.
28. de Longueville F, Surry D, Meneses-Lorente G, et al. Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochem Pharmacol. 2002;64:137-149.
29. Santegoets SJ, Schreurs MW, Masterson AJ, et al. In vitro priming of tumor-specific cytotoxicT lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line. Cancer Immunol Immunother. 2006:55:1480-1490.
30. Santegoets SJ, Bontkes HJ, StamAG, et al. Inducing antitumorT cell immunity: comparative functional analysis of interstitial versus Langerhans dendritic cells in a human cell line model. J Immunol. 2008:180:4540-4549.
31. Angenieux C, Fricker D, Strub JM, et al. Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNAand protein levels. Funct Integr Genomics. 2001:1:323-329.
32. Jeremy JY, Angelini GD, Khan M, et al. Platelets, oxidant stress and erectile dysfunction: an hypothesis. Cardiovasc Res. 2000;46:50-54.
33. LuftT, Rodionova E, Maraskovsky E, et al. Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals. Blood. 2006:107:4763-4769.
34. KambayashiT, Wallin RP, Ljunggren HG. cAMP-elevating agents suppress dendritic cell function. J Leukoc Biol. 2001;70:903-910.
35. Giordano D, Magaletti DM, Clark EA. Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-nodedirecting chemokineCCL19. Blood. 2006:107: 1537-1545.
36. Del PreteA, Shao WH. Mitola S. et al. Regulation of dendritic cell migration and adaptive immune response by leukotriene B4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function. Blood. 2007:109:626-631.
37. deWolf CJ, Yamaguchi H, van der Heijden I, et al. cGMP transport by vesicles from human and mouse erythrocytes. FEBS J. 2007:274:439-450.
38. Rius M, Thon WF, Keppler D, Nies AT. Prostanoid transport by multidrug resistance protein 4 (MRP4/ABCC4) localized in tissues of the human urogenital tract. J Urol. 2005:174:2409-2414.
39. Nies AT, Jedlitschky G, Konig J, et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience. 2004;129:349-360.
40. Denk GU, Soroka CJ, Takeyama Y, et al. Multidrug resistance-associated protein 4 is upregulated in liver but down-regulated in kidney in obstructive cholestasis in the rat. J Hepatol. 2004:40:585-591.
41. Belinsky MG, Guo P, Lee K, et al. Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogueinduced damage. Cancer Res. 2007;67:262-268.
42. m guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes. Biochem Pharmacol. 2002;63:945-949.